ADVENTRX Pharma Articles
US FDA turns down ADVENTRX NSCLC drug Exelbine
11 August 2011
ADVENTRX completes acquisition of SynthRx
14 April 2011
US FDA calls for additional study on ADVENTRX’ ANX-514
17 February 2011
Showing 1-4 of 4 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
